{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(11)"],"submitter":["Zoufaly A"],"funding":["CIHR"],"journal":["The Lancet. Respiratory medicine"],"pagination":["1154-1158"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7515587"],"repository":["biostudies-literature"],"pubmed_title":["Human recombinant soluble ACE2 in severe COVID-19."],"pmcid":["PMC7515587"],"funding_grant_id":["FDN143285","VR3-17652","137772"],"pubmed_authors":["Neuhold S","Mirazimi A","Grieb A","Stiasny K","Aberle JH","Wenisch C","Zhang H","Puchhammer-Stoeckl E","Hoepler W","Slutsky AS","Zoufaly A","Haider D","Poglitsch M","Seitz T","Penninger JM","Traugott M","Bergthaler A","Montserrat N","Laferl H","Pawelka E"],"additional_accession":[]},"is_claimable":false,"name":"Human recombinant soluble ACE2 in severe COVID-19.","description":null,"dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Nov","modification":"2025-04-18T14:55:43.41Z","creation":"2025-04-07T01:20:02.592Z"},"accession":"S-EPMC7515587","cross_references":{"pubmed":["33131609"],"doi":["10.1016/S2213-2600(20)30418-5"]}}